Ionis Pharmaceuticals has received US FDA approval for zilganersen (Zanvastro) to treat Alexander disease, a rare and ...

The collaboration is aimed at accelerating some of the most time-intensive regulatory work in drug development ...

The technologies combine machine learning, deep learning and 3D imaging to support clinicians in identifying chronic kidney ...

This, with its wholly owned subsidiary, RPG Active Pharma Limited (RPGAP), agreeing to acquire the API and intermediates ...

The analysis is based on diagnostic testing trends across its network and tracks changes in disease positivity and geographic ...

The certification was issued following an audit by SGS, an independent testing, inspection and certification company, and ...

The report examines how changing cultural attitudes toward beauty and aging are reshaping the aesthetic treatment landscap ...

The campaign combines Fortis Healthcare’s clinical expertise and hospital network with Takeda’s scientific expertise in ...

The discussions will examine how quality systems can move beyond compliance to become more predictive, risk-based and capable ...

Priority-reviewed topical JAK inhibitor now approved for children as young as two, backed by Phase III data showing 63% ...

AstraZeneca and Daiichi Sankyo’s Enhertu in combination with pertuzumab has secured European Union approval as a first-line ...

The completion of the Apogee acquisition is an important step in further strengthening AbbVie's leadership in immunology and ...